All treatments
Treatment
Immune checkpoint inhibitor clinical trials
2 indexed studies · 2 currently recruiting
- RecruitingPHASE3
Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
This study looks at treating brain tumours from melanoma or lung cancer. It compares standard treatments (like immunotherapy) plus focused radiation to standard treatments alone, aiming to find the best way to improve lives and reduce side effects.
For: Non-Small Cell Lung Cancer · MelanomaItaly · Netherlands · Spain - RecruitingPHASE1, PHASE2
Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors
This study is testing a new drug, DT-7012, both on its own and with another cancer drug, for people with advanced solid tumours. It aims to see if it's safe, what dose works best, and how well it treats the cancer. This is an early-stage study.
For: Advanced Solid TumorsUnited States · Australia · France